アピコンプレクサ寄生虫の治療薬開発 Apicomplexan Parasites : Molecular Approaches toward Targeted Drug Development (Drug Discovery in Infectious Diseases Vol.2) （2011. XXII, 528 p. w. 53 b&w and 46 col. figs. 240 mm）

アピコンプレクサ寄生虫の治療薬開発<br>Apicomplexan Parasites : Molecular Approaches toward Targeted Drug Development (Drug Discovery in Infectious Diseases Vol.2) （2011. XXII, 528 p. w. 53 b&w and 46 col. figs. 240 mm）

個数：

電子版価格
¥23,840

電子版あり

アピコンプレクサ寄生虫の治療薬開発
Apicomplexan Parasites : Molecular Approaches toward Targeted Drug Development (Drug Discovery in Infectious Diseases Vol.2) （2011. XXII, 528 p. w. 53 b&w and 46 col. figs. 240 mm）

Ed. by Katja Becker

ウェブストア価格 ¥46,756（本体¥42,506）
WILEY-VCH; WILEY-BLACKWELL（2011発売）
外貨定価 EUR 189.00
ポイント 425pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 550 p.
言語 ENG
商品コード 9783527327317

基本説明

Written by renowned scientific experts from academia and industry, the book focuses on current drug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and veterinarian pharmaceutical industry.

Full Description

This handbook is the first dealing with the discovery of drugs directed against apicomplexan parasites. Amongst others, this group of endoparasites includes the causative agents of Malaria, Toxoplasmosis, and Babesiosis, the latter occurring mainly in animals. Written by renowned scientific experts from academia and industry, the book focuses on currentdrug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and veterinarian pharmaceutical industry. This work is the second volume of the new book series 'Drug Discovery in Infectious Diseases', edited by Prof. Dr Paul M. Selzer.

SCREENING, BIOINFORMATICS, CHEMOINFORMATICS, AND DRUG DESIGN
Drug Discovery Approaches towards Anti-Parasitic Agents
(Andreas Rohwer, Richard J. Marhofer, Conor R. Caffrey and Paul M. Selzer)
New Bioinformatic Strategies against Apicomplexan Parasites
(Thomas Dandekar and Ke Xiao)
Sorting Potential Therapeutic Targets in Apicomplexa
(Jan A. Hiss and Gisbert Schneider)

Alternatives to Drug Development in Apicomplexa
(Prof. Dr. Theo P.M. Schetters)

METABOLIC PATHWAYS AND PROCESSES ADDRESSED BY CURRENT DRUG DISCOVERY APPROACHES

The Energy Metabolism as an Antimalarial Drug Target
(Esther Jortzik and Katja Becker)
Polyamines in Apicomplexan Parasites
(Ingrid B. Muller, Robin Das Gupta, Kai Luersen, Carsten Wrenger and Rolf D. Walter)
The Reducing Milieu of Parasitized Cells as a Target of Antimalarial Agents. Methylene Blue as an Ethical Drug
(Peter Meissner, Heike Adler, Karin Fritz-Wolf and R. Heiner Schirmer)
Lipids as Drug Targets for Malaria Therapy
(Henri J. Vial, Diana Penarete, Sharon Wein, Sergio Caldarelli, Laurent Fraisse and Suzanne Peyrottes)
Targeting Apicoplast Pathways in Plasmodium
(Snober S. Mir, Subir Biswas and Saman Habib)
Lipoic Acid Acquisition and Glutathione Biosynthesis in Apicomplexan Parasites
(Janet Storm, Eva-Maria Patzewitz and Sylke Muller)
Antimalarial Drugs and Molecules Inhibiting Hemozoin formation
(Uday Bandyopadhyay and Sumanta Dey)
Exploiting the Vitamin Metabolism of Apicomplexa as Drug Targets
(Carsten Wrenger and Ingrid B. Muller)

Vitamin Biosynthetic Pathways, the PLP Synthase Complex, and the Potential for Drugging Protein-Protein Interaction
(Ivo Tews and Irmgard Sinning)
Targeting Prokaryotic Enzymes in the Eukaryotic Pathogen Cryptosporidium
(Suresh Kumar Gorla, Corey Johnson, Jihan Khan, Xin Sun, Lisa Sharling,
Boris Striepen and Lizbeth Hedstrom)

DRUG TARGETS IN APICOMPLEXAN PARASITES
Novel Apicomplexan Phosphatases and Immunophilins
as Domain-Specific Drug Targets
(Sailen Barik)
Dehydrogenases and enzymes of the mitochondrial electron transport chain as antiapicomplexan drug targets
(Kathleen Zocher, Stefan Rahlfs and Katja Becker)
Calcium-dependent protein kinases as drug targets in apicomplexan parasites
(Dominik Kugelstadt, Bianca Derrer, and Barbara Kappes)

Protein Acylation:
New Potential Targets for Intervention against Apicomplexa
(Joana M. Santos, Christian Hedberg and Dominique Soldati-Favre)
Drugs and Drug Targets in Neospora Caninum and Related Apicomplexans
(Joachim Muller, Norbert Muller and Andrew Hemphill)

COMPOUNDS
Subversive Substrates of Glutathione Reductases from P. Falciparum-infected Red Blood Cells as Antimalarial Agents
(Elisabeth Davioud-Charvet and Don Antoine Lanfranchi)
Ferroquine: a Concealed Weapon (Christophe Biota, Bruno Pradinesb and Daniel Divec)

Current Aspects of Endoperoxides in Antiparasitic Chemotherapy
(Denis Matovu Kasozi, Stefan Rahlfs and Katja Becker)

Plasmodium Hsp90 as an Antimalarial Target
(G. Sridhar Prasad and Sailen Barik)
Drug Discovery against Babesia and Toxoplasma
(Mohamad Alaa Terkawi and Ikuo Igarashi)
Search for Drugs and Drug Targets against Babesia bovis, Babesia bigemina, Babesia caballi, and Babesia (Theileria) equi
(Sabine Bork-Mimm)
Orlistat: A Repositioning Opportunity as a Growth Inhibitor of Apicomplexan Parasites?
(Christian Miculka, Hon Tran, Thorsten Meyer, Anja R. Heckeroth, Stefan Baumeister, Frank Seeber and Paul M. Selzer)
Recent drug discovery against Cryptosporidium
(Jean-Francois Rossignol, Gilles Gargala, J. Edward Semple and Andrew V. Stachulski)